These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15842581)

  • 1. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
    Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
    Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The liver diseases of lipodystrophy: the long-term effect of leptin treatment.
    Safar Zadeh E; Lungu AO; Cochran EK; Brown RJ; Ghany MG; Heller T; Kleiner DE; Gorden P
    J Hepatol; 2013 Jul; 59(1):131-7. PubMed ID: 23439261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study.
    Kedarisetty CK; Bhardwaj A; Kumar G; Rastogi A; Bihari C; Kumar M; Sarin SK
    Indian J Gastroenterol; 2021 Feb; 40(1):41-49. PubMed ID: 33772456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of alanine aminotransferase levels and a histological diagnosis of steatohepatitis with ultrasound-diagnosed metabolic-associated fatty liver disease in patients from a centre in Nigeria.
    Kolawole OJ; Oje MM; Betiku OA; Ijarotimi O; Adekanle O; Ndububa DA
    BMC Gastroenterol; 2024 May; 24(1):147. PubMed ID: 38724942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
    Xanthakos SA; Lavine JE; Yates KP; Schwimmer JB; Molleston JP; Rosenthal P; Murray KF; Vos MB; Jain AK; Scheimann AO; Miloh T; Fishbein M; Behling CA; Brunt EM; Sanyal AJ; Tonascia J;
    Gastroenterology; 2020 Nov; 159(5):1731-1751.e10. PubMed ID: 32712103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial.
    Shields WW; Thompson KE; Grice GA; Harrison SA; Coyle WJ
    Therap Adv Gastroenterol; 2009 May; 2(3):157-63. PubMed ID: 21180541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis.
    Sobhonslidsuk A; Jongjirasiri S; Thakkinstian A; Wisedopas N; Bunnag P; Puavilai G
    World J Gastroenterol; 2007 Jul; 13(26):3614-8. PubMed ID: 17659713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance.
    Demirtas CO; Sapmaz A; Gurel BA; Kizmaz H; Ulu T; Karaketir SG; Hidiroglu S; Yilmaz Y
    Hepatol Forum; 2020 Sep; 1(3):101-108. PubMed ID: 35949721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Weight Changes With Changes in Histological Features and Blood Markers in Nonalcoholic Steatohepatitis.
    Koutoukidis DA; Jebb SA; Tomlinson JW; Cobbold JF; Aveyard P
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e538-e547. PubMed ID: 33813074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study.
    Armandi A; Bespaljko H; Mang A; Huber Y; Michel M; Labenz C; Galle PR; Neerukonda M; Bugianesi E; Schuppan D; Schattenberg JM
    Aliment Pharmacol Ther; 2024 May; 59(10):1212-1222. PubMed ID: 38462919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Mobile Lifestyle Intervention Combined with High-Protein Meal Replacement on Liver Function in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Randomized Controlled Trial.
    Cho E; Kim S; Kim S; Kim JY; Kim HJ; Go Y; Lee YJ; Lee H; Gil S; Yoon SK; Chu K
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive measure of treatment response in non-alcoholic steatohepatitis: Insights from EMMINENCE and meta-analysis.
    Davison BA; Edwards C; Loomba R; Harrison SA; Cotter G; Alkhouri N; Koch GG; Dittrich HC
    JGH Open; 2021 Jul; 5(7):740-749. PubMed ID: 34263067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of newly developed food for special dietary use in the diet of patients with non-alcoholic steatohepatitis].
    Sasunova AN; Morozov SV; Sobolev RV; Isakov VA; Kochetkova AA; Vorobyeva IS
    Vopr Pitan; 2022; 91(2):31-42. PubMed ID: 35596633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency and long persistency of ballooning hepatocyte were associated with glucose intolerance in patients with severe obesity.
    Kakisaka K; Sasaki A; Umemura A; Nikai H; Suzuki Y; Nishiya M; Sugai T; Nitta H; Takikawa Y
    Sci Rep; 2021 Jul; 11(1):15392. PubMed ID: 34321567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis.
    Ćulafić M; Vezmar-Kovačević S; Dopsaj V; Oluić B; Bidžić N; Miljković B; Ćulafić Đ
    J Med Biochem; 2020 Sep; 39(3):290-298. PubMed ID: 33269017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH).
    Lee YM; Sutedja DS; Wai CT; Dan YY; Aung MO; Zhou L; Cheng CL; Wee A; Lim SG
    Hepatol Int; 2008 Jun; 2(2):196-201. PubMed ID: 19669304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastographic liver evaluation of Katukyadi churna in the management of Non-Alcoholic Steatohepatitis (NASH) - A single arm clinical trial.
    Tarapure S; Tubaki BR; Khot S
    J Ayurveda Integr Med; 2021; 12(1):136-142. PubMed ID: 33579578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study.
    Hadefi A; Verset L; Pezzullo M; Rosewick N; Degré D; Gustot T; Moreno C; Devière J; Trépo E
    Endosc Int Open; 2021 Nov; 9(11):E1792-E1800. PubMed ID: 34790547
    [No Abstract]   [Full Text] [Related]  

  • 19. The Effects of
    Jamali A; Karbalai S; Tefagh G; Jamali R; Ahmadi A
    Middle East J Dig Dis; 2022 Jan; 14(1):85-95. PubMed ID: 36619724
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration.
    Palmieri B; Corazzari V; Panariello Brasile DG; Sangiovanni V; VadalÀ M
    Minerva Gastroenterol Dietol; 2020 Dec; 66(4):307-320. PubMed ID: 33443240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.